A new fact sheet on Varenicline (the generic name for Chantix), the newly approved smoking cessation drug. It’s the first drug to target nicotine receptors.
Published by Jason Schwartz
I have been an addiction professional and social worker since 1994. I started blogging in 2005 as the Clinical Director at Dawn Farm. I no longer work at Dawn Farm and am now the Director of Behavioral Medicine at a community hospital, and a lecturer at Eastern Michigan University’s School of Social Work. Views expressed here are my own. Keep in mind that the field, the contexts in which the field operates, and my views have changed over time. View all posts by Jason Schwartz